PT - JOURNAL ARTICLE AU - Jean-Claude Lavoie AU - Thérèse Rouleau AU - Philippe Chessex TI - Interaction between Ascorbate and Light-Exposed Riboflavin Induces Lung Remodeling AID - 10.1124/jpet.104.070755 DP - 2004 Nov 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 634--639 VI - 311 IP - 2 4099 - http://jpet.aspetjournals.org/content/311/2/634.short 4100 - http://jpet.aspetjournals.org/content/311/2/634.full SO - J Pharmacol Exp Ther2004 Nov 01; 311 AB - Light-exposed parenteral multivitamins induce in lungs peroxide-like oxidant responses as well as the initiation of fibrosis. We hypothesized that peroxides generated in light-exposed total parenteral nutrition (TPN) affect lung remodeling. The objective was to assess the specific roles of peroxides, multivitamin preparation (MVP), and light exposure on lung remodeling during TPN. Three-day-old guinea pigs fitted with an indwelling catheter were assigned to the following intravenous regimens: TPN or MVP ± photoprotection, H2O2± glutathione, MVP ± metabisulfite, or ascorbic acid ± riboflavin. Fed animals served as controls. After 4 days, lungs were sampled to determine alveolarization (intercepts), β-actin mRNA (protection assay), and apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling). Data were analyzed by analysis of variance. The infusion of light-exposed multivitamins induced a 20% lower (p < 0.01) alveolarization index than fed controls, and 3-fold higher (p < 0.01) apoptotic events. This was prevented by photoprotecting TPN. The effect of multivitamins on the alveolarization index was reproduced (p < 0.05) by infusion of light-exposed riboflavin in the presence of vitamin C. The alveolarization index correlated (r2 = 0.35; p < 0.05) with β-actin mRNA, suggesting alveolar disruption. Antiperoxides conferred no protection against decreased alveolarization. Lung remodeling induced by exposure of TPN to ambient light is not due to a direct effect of infused peroxides but rather to an interaction between vitamin C and peroxides generated by the exposure of riboflavin to light. It is speculated that this interaction may play a role in the development of chronic lung disease of premature infants who receive TPN and have immature antioxidant defenses. The American Society for Pharmacology and Experimental Therapeutics